These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21394553)

  • 1. Non-invasive risk assessment in patients with chronic kidney disease.
    Hakeem A; Bhatti S; Trevino AR; Samad Z; Chang SM
    J Nucl Cardiol; 2011 May; 18(3):472-85. PubMed ID: 21394553
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac risk assessment by gated single-photon emission computed tomography in asymptomatic end-stage renal disease patients at the start of dialysis.
    Kim JK; Kim SG; Kim HJ; Song YR
    J Nucl Cardiol; 2012 Jun; 19(3):438-47. PubMed ID: 22203446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.
    Doukky R; Fughhi I; Campagnoli T; Wassouf M; Ali A
    J Nucl Cardiol; 2017 Feb; 24(1):112-118. PubMed ID: 26582040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial perfusion SPECT "screening" at the start of dialysis.
    Bhatti S; Hakeem A
    J Nucl Cardiol; 2012 Jun; 19(3):410-1. PubMed ID: 22351493
    [No Abstract]   [Full Text] [Related]  

  • 5. Single-photon emission computed tomography myocardial perfusion defects are associated with an increased risk of all-cause death, cardiovascular death, and sudden cardiac death.
    Piccini JP; Horton JR; Shaw LK; Al-Khatib SM; Lee KL; Iskandrian AE; Borges-Neto S
    Circ Cardiovasc Imaging; 2008 Nov; 1(3):180-8. PubMed ID: 19808541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of myocardial perfusion imaging and coronary artery calcium measurements in patients with end-stage renal disease.
    Havel M; Kaminek M; Metelkova I; Budikova M; Henzlova L; Koranda P; Zadražil J; Kincl V
    Hell J Nucl Med; 2015; 18(3):199-206. PubMed ID: 26574691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The time and place for appropriate radionuclide imaging: now and everywhere.
    Hendel RC; Thomas GS
    J Nucl Cardiol; 2011 Dec; 18(6):997-9. PubMed ID: 21837539
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic impact of SPECT-MPI after renal transplantation.
    Abuzeid W; Iwanochko RM; Wang X; Kim SJ; Husain M; Lee DS
    J Nucl Cardiol; 2017 Feb; 24(1):295-303. PubMed ID: 27663251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental prognostic value of myocardial perfusion imaging in patients referred to stress single-photon emission computed tomography with renal dysfunction.
    Al-Mallah MH; Hachamovitch R; Dorbala S; Di Carli MF
    Circ Cardiovasc Imaging; 2009 Nov; 2(6):429-36. PubMed ID: 19920040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome is not a predictor for cardiovascular events in Japanese patients with diabetes mellitus asymptomatic for coronary artery disease: a retrospective analysis of the J-ACCESS-2 study.
    Nakajima K; Takeishi Y; Matsuo S; Yamasaki Y; Nishimura T
    J Nucl Cardiol; 2013 Apr; 20(2):234-41. PubMed ID: 23196975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical value of single photon emission computed tomography myocardial perfusion imaging in cardiac risk stratification of very elderly patients (≥80 years) with suspected coronary artery disease.
    Nair SU; Ahlberg AW; Mathur S; Katten DM; Polk DM; Heller GV
    J Nucl Cardiol; 2012 Apr; 19(2):244-55. PubMed ID: 22071954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomograms for estimating coronary artery disease prognosis with gated stress myocardial perfusion SPECT.
    Shaw LJ; Min JK; Hachamovitch R; Hendel RC; Borges-Neto S; Berman DS
    J Nucl Cardiol; 2012 Feb; 19(1):43-52. PubMed ID: 22045394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk assessment with regadenoson SPECT MPI in patients with end-stage renal disease is safe, effective, and well tolerated: Does it matter?
    Miller EO; Schwartz RG
    J Nucl Cardiol; 2017 Feb; 24(1):119-121. PubMed ID: 26626782
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of regadenoson in end-stage renal disease.
    Iskandrian AE; Hage FG; Heo J
    J Nucl Cardiol; 2013 Apr; 20(2):182-4. PubMed ID: 23225540
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular risk stratification in diabetic patients following stress single-photon emission-computed tomography myocardial perfusion imaging: the impact of achieved exercise level.
    Padala SK; Ghatak A; Padala S; Katten DM; Polk DM; Heller GV
    J Nucl Cardiol; 2014 Dec; 21(6):1132-43. PubMed ID: 25208530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening asymptomatic patients with type 2 diabetes is recommended-Con.
    Gibbons RJ
    J Nucl Cardiol; 2015 Dec; 22(6):1229-32. PubMed ID: 26391500
    [No Abstract]   [Full Text] [Related]  

  • 17. Screening asymptomatic patients with type 2 diabetes is recommended: Pro.
    Petretta M; Cuocolo A
    J Nucl Cardiol; 2015 Dec; 22(6):1225-8. PubMed ID: 26391499
    [No Abstract]   [Full Text] [Related]  

  • 18. Appropriateness of referrals for single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) in a developing community: a comparison between 2005 and 2009 versions of ACCF/ASNC appropriateness criteria.
    Gholamrezanezhad A; Shirafkan A; Mirpour S; Rayatnavaz M; Alborzi A; Mogharrabi M; Hassanpour S; Ramezani M
    J Nucl Cardiol; 2011 Dec; 18(6):1044-52. PubMed ID: 21818700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential risk reclassification improvement by exercise testing and myocardial perfusion imaging in patients with suspected and known coronary artery disease.
    Koh AS; Gao F; Chin CT; Keng FY; Tan RS; Chua TS
    J Nucl Cardiol; 2016 Jun; 23(3):366-78. PubMed ID: 26358085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease.
    AlJaroudi W; Campagnoli T; Fughhi I; Wassouf M; Ali A; Doukky R
    J Nucl Cardiol; 2016 Jun; 23(3):560-9. PubMed ID: 26293358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.